CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a method for predicting effective combinations of existing cancer drugs using minimal experimental data. By focusing on personalized treatment strategies, it seeks to enhance cancer therapy through optimized drug cocktails tailored to individual tumors.
Cancer is a global epidemic that affects all ages and socio-economic groups.
In turn, tremendous resources are being invested in prevention, diagnosis, and treatment of cancer.
For instance, over 1,000 anticancer drugs are currently in various phases of development and pre-approval testing, more than the number for heart disease, stroke, and mental illness combined.
Finding multi-drug combinations for cancer is an increasingly pressing therapeutic challenge.
However, screening all possible drug…
WEIZMANN INSTITUTE OF SCIENCE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
